An overview of biomarkers in Alzheimer’s disease
2010

Overview of Biomarkers in Alzheimer's Disease

publication Evidence: moderate

Author Information

Author(s): Wattamwar Pandurang R, Mathuranath P. S.

Primary Institution: Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST)

Hypothesis

The study aims to identify and discuss various candidate biomarkers for early diagnosis of Alzheimer's disease.

Conclusion

The quest for an ideal biomarker for Alzheimer's disease continues despite significant advances in the field.

Supporting Evidence

  • Alzheimer's disease is the most common progressive neurodegenerative disease affecting the elderly.
  • Biomarkers can help detect Alzheimer's disease at an early stage.
  • Current diagnostic criteria fail to identify patients in the prodromal or preclinical stages.

Takeaway

Scientists are looking for special markers that can help find Alzheimer's disease early, even before symptoms show up.

Methodology

The review discusses various candidate biomarkers in five spheres: biochemical, neuroanatomical, metabolic, genetic, and neuropsychological.

Limitations

The lack of complete understanding of the underlying pathogenic process and the unavailability of histopathological diagnosis during life are major barriers.

Digital Object Identifier (DOI)

10.4103/0972-2327.74256

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication